Boston Scientific authorizes repurchase of up to $1B in stock Says repurchased approximately 18M shares under 2011 share repurchase authorization. Separately, the company announced the authorization of a new program to repurchase up to $1B of its common stock.
News For BSX From The Last 14 Days
Check below for free stories on BSX the last two weeks.
Boston Scientific reports favorable results for Precision Spectra New retrospective data highlighting the Boston Scientific Precision Spectra Spinal Cord Stimulator System demonstrate the device provided highly significant pain relief three months after implantation. The company reported a 94% SCS trial therapy success rate, a highly significant reduction in paint, and improvements in function, including walking and sleeping.